Thank you OncoDaily for the chance to review the progress we've made in understanding & treating #Liposarcoma, a rare #sarcoma of fat cells - including targeted, immune, + cellular therapies & the work we need to do to improve outcomes Shushan Hovsepyan Dana-Farber Dana-Farber News